发明名称 ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES.
摘要 <p>alpha-Amino hydroxamic acid derivative of formula (I), in which R is C2-C7-alkyl, which is mono-, di- or trisubstituted by halogen, nitro, lower acyloxy, trifluoromethoxy, cyano, C3-C5-cycloalkyl or unsubstituted or substituted C3-C6-heteroaryl comprising one or two heteroatoms selected from the group consisting of O, S and N; or C3-C7-alkenyl or C3-C7-alkynyl, which in each case is unsubstituted or mono-, di- or trisubstituted by halogen, nitro, lower acyloxy, trifluoromethoxy, cyano, C3-C5-cycloalkyl or unsubstituted or substituted C3-C6-heteroaryl comprising one or two heteroatoms selected from the group consisting of O, S and N; and the other symbols are as defined in claim 1, are described. These compounds are MMP and in particular MMP2 inhibitors and can be used for treatment of MMP dependent diseases, in particular inflammation conditions, rheumatoid arthritis, osteoarthritis, tumors (tumor growth, metastasis, progression or invasion) and pulmonary disorders (e.g. emphysema, COPD).</p>
申请公布号 MXPA02001418(A) 申请公布日期 2002.07.30
申请号 MX2002PA01418 申请日期 2000.08.07
申请人 NOVARTIS AG 发明人 SAKAKI, JUNICHI
分类号 A61K31/16;A61K31/18;A61K31/4164;A61K31/4196;A61K31/4402;A61K31/4406;A61K31/445;A61K31/5375;A61P11/06;A61P19/02;A61P29/00;A61P35/00;A61P43/00;C07C303/40;C07C309/42;C07C311/29;C07D207/32;C07D207/325;C07D211/28;C07D213/42;C07D215/12;C07D233/54;C07D233/61;C07D249/06;C07D249/08;C07D257/04;C07D295/12;C07D295/125;C07D295/13;C07D295/135;C07D307/52;C07D333/20;C07D405/12;C07D521/00;(IPC1-7):A61K31/18;C07D211/58;A61K31/33 主分类号 A61K31/16
代理机构 代理人
主权项
地址